Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival

Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Laurie E. Harrington, Robin D. Hatton, Paul R. Mangan et al. · Nature Immunology · 2005 · 4.7K citations

Life Sciences, Cell Biology, Immunology +17

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

Spencer C. Liang, Xiangyang Tan, Deborah Luxenberg et al. · The Journal of Experimental Medicine · 2006 · 2.3K citations · Full text

Life Sciences, Immunology, Microbiology +17

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

Yan Zheng, Patricia Valdez, Dimitry M. Danilenko et al. · Nature Medicine · 2008 · 1.9K citations

Life Sciences, Immunology, Microbiology +16

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

Tyler J. Curiel, Shuang Wei, Haidong Dong et al. · Nature Medicine · 2003 · 1.3K citations

Life Sciences, Immunology, Oncology +15

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

Stefanie Eyerich, Kilian Eyerich, Davide Pennino et al. · Journal of Clinical Investigation · 2009 · 1K citations · Full text

Life Sciences, Dermatology, Immunology +17